Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bo Olsson is active.

Publication


Featured researches published by Bo Olsson.


Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung | 2003

Next Generation Pharmaceutical Impactor (A New Impactor for Pharmaceutical Inhaler Testing). Part I: Design

Virgil A. Marple; Daryl L. Roberts; Francisco J. Romay; Nicholas C. Miller; Keith Truman; Michiel Van Oort; Bo Olsson; Michael J. Holroyd; Jolyon P. Mitchell; Dieter Hochrainer

A new cascade impactor has been designed specifically for pharmaceutical inhaler testing. This impactor, called the Next Generation Pharmaceutical Impactor (NGI), has seven stages and is intended to operate at any inlet flow rate between 30 and 100 L/min. It spans a cut size (D50) range from 0.54-microm to 11.7-microm aerodynamic diameter at 30 L/min and 0.24 microm to 6.12 microm at 100 L/min. The aerodynamics of the impactor follow established scientific principles, giving confident particle size fractionation behavior over the design flow range. The NGI has several features to enhance its utility for inhaler testing. One such feature is that particles are deposited on collection cups that are held in a tray. This tray is removed from the impactor as a single unit, facilitating quick sample turn-around times if multiple trays are used. For accomplishing drug recovery, the user can add up to approximately 40 mL of an appropriate solvent directly to the cups. Another unique feature is a micro-orifice collector (MOC) that captures in a collection cup extremely small particles normally collected on the final filter in other impactors. The particles captured in the MOC cup can be analyzed in the same manner as the particles collected in the other impactor stage cups. The user-friendly features and the aerodynamic design principles together provide an impactor well suited to the needs of the inhaler testing community.


Aerosol Science and Technology | 1997

Calibration at Different Flow Rates of a Multistage Liquid Impinger

Lars Asking; Bo Olsson

ABSTRACT The multistage liquid impinger (MLI) is an impactor suitable for size-selective characterization and testing of pharmaceutical inhalation products, especially dry powder inhalers (DPIs). The four-stage version of the MLI, which was adopted by the European Pharmacopoeia for testing at 60 L/min, has been calibrated by two different laboratories (Astra Draco AB, Sweden, and AEA Technology, UK), reaching consistent results. The MLI has been extended with an additional impaction stage and all impaction stages have been calibrated at flow rates of 30, 40, 50, 60, 80, and 100 L/min. It is shown that in this flow range, the cutoff diameter depends on the flow rate according to a simplified impaction equation, i.e., the cutoff diameter is proportional to the inverse of the square root of the flow rate. Based on the calibration data and the simplified equation, a cutoff value for any flow rate in the range 30–100 L/min can be assigned. This is an important possibility as a DPI should be tested at a flow ra...


Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung | 2006

Degree of throat deposition can explain the variability in lung deposition of inhaled drugs.

Lars Borgström; Bo Olsson; Lars Thorsson


Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung | 1995

Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers?

Bo Olsson


Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung | 1994

Critical Aspects of the Function of Inspiratory Flow Driven Inhalers

Bo Olsson; Lars Asking


Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung | 2007

Studies of the human oropharyngeal airspaces using magnetic resonance imaging IV--the oropharyngeal retention effect for four inhalation delivery systems.

Patricia K.P. Burnell; Lars Asking; Lars Borgström; Steve Nichols; Bo Olsson; David Prime; Ian Shrubb


Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung | 1994

A Model for the Effect of Inhalation Device Flow Resistance on the Peak Inspiratory Flow Rate and Its Application in Pharmaceutical Testing

Bo Olsson; Lars Asking


Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung | 2005

Dose delivery late in the breath can increase dry powder aerosol penetration into the lungs.

Eva Bondesson; Thomas Bengtsson; Lars Borgström; Lars-Erik Nilsson; Kristina Norrgren; Bo Olsson; Mårten Svensson; Per Wollmer


Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung | 1997

Can in Vitro Measurements Predict the Lung Deposition of Dry-Powder Inhalers?

Bo Olsson


Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung | 1998

Discrepancy between In Vitro and In Vivo Dose Variability for a Pressurized Metered Dose Inhaler and a Dry Powder Inhaler

Lars Borgström; L. Asking; O. Beckman; Eva Bondesson; A. Källén; Bo Olsson

Collaboration


Dive into the Bo Olsson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge